BSH 2019 | Novel IMiD-based compounds and combinations

Sagar Lonial

Speaking at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK, Sagar Lonial, MD, FACP, Emory University, Atlanta, GA, discusses the mechanism of action of IMiDs, and novel IMiD-based compounds and combinations in multiple myeloma.

Share this video  
Similar topics